rs12722489

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_000417.3(IL2RA):c.64+2039G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.106 (AC=16,152) in the gnomAD database across 152,076 control chromosomes, including 1,103 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.153. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1103 hom., cov: 31)

Consequence

IL2RA
NM_000417.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0320

Publications

112 publications found
Variant links:
Genes affected
IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]
IL2RA Gene-Disease associations (from GenCC):
  • immunodeficiency due to CD25 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
  • neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • type 1 diabetes mellitus 10
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000417.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.1527 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000417.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL2RA
NM_000417.3
MANE Select
c.64+2039G>A
intron
N/ANP_000408.1P01589
IL2RA
NM_001308242.2
c.64+2039G>A
intron
N/ANP_001295171.1Q5W005
IL2RA
NM_001308243.2
c.64+2039G>A
intron
N/ANP_001295172.1H0Y5Z0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL2RA
ENST00000379959.8
TSL:1 MANE Select
c.64+2039G>A
intron
N/AENSP00000369293.3P01589
IL2RA
ENST00000379954.5
TSL:1
c.64+2039G>A
intron
N/AENSP00000369287.1Q5W005
IL2RA
ENST00000447847.2
TSL:1
c.64+2039G>A
intron
N/AENSP00000402024.2H0Y5Z0

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.106
AC:16165
Hom:1107
AN:151958
Cov:31
GnomAD4 genome
AF: 0.106
AC:16152
Hom:1103
AN:152076
Cov:31
TOPMed (Bravo)
AF: 0.0995
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.138
AC:90032
Hom:6719
AN:651304
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.0956
AC:224
Hom:13
AN:2342
ChinaMAP Phase 1
AF: 0.129
Denmark Genome
AF: 0.173
AC:52
AN:300
GenomeAsia100K
AF: 0.141
AC:490
AN:3478
Korea4K (4,157 Koreans)
AF: 0.109
AC:785
AN:7234
Qatari Genome
AF: 0.0398
AC:7
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.103
AC:12620
Hom:679
AN:122696
Turkish Variome
AF: 0.0724
AC:112
Hom:7
AN:1546
UK10K
AF: 0.163
AC:1234
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.137
AC:1224
Hom:100
AN:8960
Showing 14 sources
Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign0.65
BayesDel_noAF
Benign-0.90
CADD
Benign1.5
DANN
Benign0.53
GPN-Star LLR
N/A0.35
GPN-Star score
N/A-0.35
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign0.032
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.